XML 51 R37.htm IDEA: XBRL DOCUMENT v3.21.1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Weighted-average assumptions used to estimate fair value of restricted stock units Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement.
Three Months Ended March 31,20212020
Fair value per stock award$171.63 $94.98 
Grant date stock price$141.59 $83.93 
Assumptions:
Aptar's stock price expected volatility21.40 %23.80 %
Expected average volatility of peer companies50.00 %48.50 %
Correlation assumption58.10 %63.50 %
Risk-free interest rate0.32 %0.31 %
Dividend yield assumption1.02 %1.72 %
Summary of restricted stock unit activity
A summary of RSU activity as of March 31, 2021 and changes during the three month period then ended is presented below:
Time-Based RSUsPerformance-Based RSUs
UnitsWeighted Average
Grant-Date Fair Value		UnitsWeighted Average
Grant-Date Fair Value
Nonvested at January 1, 2021576,198 $92.47 590,064 $100.27 
Granted128,297 137.97 169,268 152.47 
Vested(118,349)89.95 (71,994)128.70 
Forfeited(2,785)95.77 (31,338)91.23 
Nonvested at March 31, 2021583,361 $106.33 656,000 $111.05 
Schedule of compensation expense, fair value, and intrinsic value related to RSU's
Three Months Ended March 31,20212020
Compensation expense$11,262 $8,281 
Fair value of units vested19,116 9,303 
Intrinsic value of units vested25,699 11,475 
Summary of option activity A summary of option activity under our stock plans during the three months ended March 31, 2021 is presented below:
Stock Awards PlansDirector Stock Option Plans
OptionsWeighted Average
Exercise Price		OptionsWeighted Average
Exercise Price
Outstanding, January 1, 20213,998,047 $70.28 99,200 $60.80 
Granted— — — — 
Exercised(507,468)63.37 (29,500)58.76 
Forfeited or expired(4,519)75.27 — — 
Outstanding at March 31, 20213,486,060 $71.28 69,700 $61.66 
Exercisable at March 31, 20213,486,060 $71.28 69,700 $61.66 
Weighted-Average Remaining Contractual Term (Years):
Outstanding at March 31, 20214.72.5
Exercisable at March 31, 20214.72.5
Aggregate Intrinsic Value:
Outstanding at March 31, 2021$245,389 $5,577 
Exercisable at March 31, 2021$245,389 $5,577 
Intrinsic Value of Options Exercised During the Three Months Ended:
March 31, 2021$37,454 $2,474 
March 31, 2020$18,202 $1,385 
Schedule of compensation expense, and fair value related to options
Three Months Ended March 31,20212020
Compensation expense (included in SG&A)$185 $743 
Compensation expense (included in Cost of sales)42 117 
Compensation expense, Total$227 $860 
Compensation expense, net of tax174 648 
Grant date fair value of options vested2,421 7,565